This up-and-coming cancer treatment could be a $25 billion market opportunity — it’s already a hotbed for M&A
Targeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma. Source link
Read MoreTargeted radiopharmaceuticals, which deliver radiation directly into tumors, has caught the eye of big pharma. Source link
Read MoreRadiopharmaceuticals seek to destroy cancer cells by binding a radioactive particle to a targeted molecule and then dispatching it directly
Read MoreThese are the stocks posting the largest moves in midday trading. Source link
Read MoreCNBC Pro screened for global stocks that have had their upside potential cut over the past seven days and ahead
Read MoreOver the last 12 months, just 11 stocks made up half of the gains that powered the pan-European Stoxx 600
Read More"In difficult times, Swiss equities, besides the U.S., is one of the markets to buy," says Vontobel Asset Management's Carla
Read MoreCNBC's Jim Cramer told investors to pay attention next week to the JPMorgan Healthcare Conference. Source link
Read MoreNext year could set the precedent for the Inflation Reduction Act's controversial talks, which could affect dozens of medications by
Read MoreThe health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have
Read More